Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis.
OBJECTIVE: Chemerin is a novel adipokine. Previous research has investigated the association between chemerin and clinical indices in patients with obesity or metabolic syndrome (MS), although the results obtained have been inconsistent. We conducted a meta-analysis to investigate the association be...
Main Authors: | Ya Li, Bingyin Shi, Sheli Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4254750?pdf=render |
Similar Items
-
Serum Chemerin Levels Correlate With Determinants of Metabolic Syndrome in Obese Children and Adolescents
by: Hong-Jun Ba, et al.
Published: (2019-06-01) -
The association between serum chemerin concentration and polycystic ovarian syndrome
by: Haghighi S, et al.
Published: (2012-08-01) -
Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome
by: Anna Szpakowicz, et al.
Published: (2021-08-01) -
Probiotics Improve Chemerin Levels and Metabolic Syndrome Parameters in Obese Rats
by: Menşure Nur Çelik, et al.
Published: (2019-09-01) -
Serum Calprotectin and Chemerin Concentrations as Markers of Low-Grade Inflammation in Prepubertal Children with Obesity
by: Grażyna Rowicka, et al.
Published: (2020-10-01)